Industry Experts – Market Research Reports

Industry Experts caters the market research needs of a broad range of industry verticals comprising Automotive, Healthcare, Food & Beverage, Telecom & Internet, Chemicals & Plastics, Biotechnology and Consumer Goods. The company also provides customized market research and industry analysis services for a wide range of industry sectors.

03 Aug

Ageing Population and Burden of Disease Contribute to Growth in Demand for IVD to Reach $83 Billion by 2022

Posted in News on 03.08.17 by IE Admin

Industry Experts released the 2017 version of its global report on In Vitro Diagnostics market. The new report titled ‘In Vitro Diagnostics – A Global Market Overview’ analyzes the global market of In Vitro Diagnostics (IVD) by geographic region, major country and prominent IVD technologies while special citation on end-use sectors in the United States and German markets. Clinical Chemistry is estimated to be the principal technology segment in the global IVD market cornering a market of $19.7 billion in 2017.

The In Vitro Diagnostics (IVD) industry is being positively impacted due to several factors that include rising global and regional trends of aging populations, growth in non-communicable diseases and greater affordability for treatment. Due to an increase in healthcare costs, greater weight is being given to evidence-based medicine with the aim of improving patient outcomes. The need for diagnostic devices in various conditions has been growing due to an aging population, growing epidemic of chronic diseases and (re)emergence of infectious diseases. A larger number of people are now gaining access to IVD due to growth in emerging countries and an impetus towards decentralized healthcare.

Nearly 68% of the global aged population resides in the developing economies and their population is increasing at a faster rate than that of developed regions. In fact, the population of aged individuals in developed economies has been exhibiting a declining trend, as can be seen from a fall of 38% in 2000 to 33% in 2015, which is likely to continue. This implies that the number of older people in the developing regions will grow over the coming decades.

The study analyzes the IVD product types including Reagents & Consumables and Instruments & Systems. This report exclusively analyzes the global IVD technology areas comprising Immunoassay, Blood Testing, Clinical Chemistry, Diabetes Testing, Molecular Diagnostics, Cellular Analysis, Pathology and Microbiology in terms of value in USD for 2014-2022 analysis period in the global markets comprising North America, Europe, Asia-Pacific, South America and Rest of World. The regional markets further analyzed for 16 independent countries across North America – The United States, Canada and Mexico; Europe – (Western Europe and Eastern Europe) Western Europe – Germany, France, Italy, Spain, the United Kingdom, Belgium and Switzerland; and Eastern Europe – Poland, Czech Republic and Romania; Asia-Pacific – Japan, China and India; South America – Argentina and Brazil.

global in vitro diagnostics market

Global IVD market grew from $55.8 billion in 2014 to US$62.6 billion in 2017 and the market is further expected to reach US$83.03 billion by 2022. Molecular Diagnostics is projected to record the fastest growing IVD technology segment with a CAGR of around 8% during 2017-2022 analysis period and to touch US$10.5 billion by 2022.

This 498 page global in-vitro diagnostics market report includes 270 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. The report profiles 13 key global players and 44 major players across North America – 26; Europe – 14 and Asia-Pacific – 4. The study also provides the listing of the companies engaged in IVD industry. The global list of companies covers the address, contact numbers and the website addresses of 335 companies.

California, USA based Industry Experts, Inc. is a multi industry focused business information provider.

For more details, please visit http://industry-experts.com/verticals/healthcare-and-pharma/in-vitro-diagnostics-a-global-market-overview

tags: , , ,

No Comments »

14 May

In Vitro Diagnostics Global Market to grow by 4.9% (2008-2018) to reach $72.7 billion by 2018

Posted in Healthcare, News on 14.05.12 by IE Admin

Hyderabad – Industry Experts, a multi industry focused market research firm, has today added a new market research report ‘In Vitro Diagnostics – A Global Market Overview’ to its Healthcare catalogue. According to the report molecular diagnostics is the fastest growing segment of global IVD market with a CAGR of 6.4% during 2008-2018 to reach US$5.3 billion by 2018. The market for glabal IVDs is estaimated to touch US$51.2 billion in 2012.

The In Vitro Diagnostic (IVD) industry has been confronting a range of issues, such as regulations, industry consolidation, reforms in healthcare, low level of technological innovations and ever-changing demographics. Though some of these challenges may seem insurmountable, the glimmer of hope always exists that could rejuvenate the IVD industry over the coming years. Improvement in healthcare infrastructure, growth in personalized medicine based on bespoke solutions and companies’ focus towards growth-centric emerging markets certainly constitute some of the major factors that can be looked up to.

The arrival of novel technologies and innovations has spawned assays and biomarkers that would play crucial roles in the high-growth areas of infectious diseases, women’s health, cancer and cardiovascular conditions. Molecular diagnostics and the genomic reform have been the primary drivers of this growth, which are expected to sustain this level not only by tailoring existing drug therapies for individual patients, but also through developing new drug therapies that would enable in the better identification of patient populations that could prospectively benefit from drug treatment. Companies would do well to concentrate on tests based on biomarkers, such as those utilizing protein-based biomarkers for Alzheimer’s disease, and the genomic revolution, with solutions using gene-based testing for indicating the probability of a range of cancers.

Though it may seem that the IVD industry is at a vital crossroad, looking hither and thither, the key point remains focusing on the above-mentioned areas to garner adequate standing that would enable in a complete turnaround. Personalized medicine appears to be a crucial aspect that has to be looked into with detail, so as to ascertain where the future of this industry lies.

The report reviews, analyses and projects IVD market for global and the regional markets including North America, Europe, Asia-Pacific, South America and Rest of World. The regional markets further analyzed for 22 independent countries across North America – United States, Canada and Mexico; Europe – Western Europe (Germany, France, Italy, Spain, United Kingdom, Belgium, Netherlands, Switzerland, Portugal, Austria, Greece, Scandinavia and Rest of Western Europe) and Eastern Europe (Poland, Czech Republic, Russia and Rest of Eastern); Asia-Pacific –Japan, China, India and Rest of Asia-Pacific; South America – Argentina, Brazil and Rest of South America; and Rest of World.

Market for IVD product categories analyzed in this study includes Reagents & Consumables and Instruments & Systems. The report also includes the market analysis for end-use application analysis of IVDs – Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology.

This 493 page global market report includes 284 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of the market. The statistical tables represent the data for the global market by geographic region, product category and application area. The report comprises the brief business profiles of 47 key global players and 60 major players across the United States – 36; Europe – 18; and Asia-Pacific – 6. The report also provides the listing of the companies engaged in research and development, equipment manufacturing, processing, supplies and distribution of In Vitro Diagnostics. The global list covers the addresses, contact numbers and the website addresses of 382 companies.

For more details, please visit http://industry-experts.com/verticals/healthcare/in-vitro-diagnostics-a-global-market-overview.html

tags: , , ,

One comment »